Where Science Meets Technology by Appsilon is a series of interviews and discussions focused on how technology can accelerate data science processes, particularly within life sciences and biopharmaceutical companies.
Each episode will explore various aspects of innovation and its potential to address challenges where traditional methods may fall short. We will feature internal experts from our delivery teams, along with clients and partners as guest speakers, providing valuable insights into the intersection of science and technology.
The podcast is brought to you by Appsilon.
Appsilon empowers Fortune 500 companies to leverage open-source technology for faster, data-driven decision-making in regulated environments
All content for 🤖🧬 Where Technology Meets Science is the property of Appsilon and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Where Science Meets Technology by Appsilon is a series of interviews and discussions focused on how technology can accelerate data science processes, particularly within life sciences and biopharmaceutical companies.
Each episode will explore various aspects of innovation and its potential to address challenges where traditional methods may fall short. We will feature internal experts from our delivery teams, along with clients and partners as guest speakers, providing valuable insights into the intersection of science and technology.
The podcast is brought to you by Appsilon.
Appsilon empowers Fortune 500 companies to leverage open-source technology for faster, data-driven decision-making in regulated environments
#007 How Open Source and Community Efforts Drive R-Based FDA Submissions
🤖🧬 Where Technology Meets Science
35 minutes
6 months ago
#007 How Open Source and Community Efforts Drive R-Based FDA Submissions
#datascience #dataanalysis #technology #datascience #opensource #pharmaverse #pharma #dataanalysis #clinicaltrials In this episode, Ben Straub, Principal Programmer at GSK, explores the shift from proprietary software to open source tools in the pharmaceutical industry. He shares insights into regulatory challenges, the rise of R, and the impact of {admiral} and other open-source packages on clinical data analysis and submissions. From pilot programs to enterprise-wide adoption, learn why collaboration is key to reducing risk and shaping the future of regulatory workflows.
In this episode, you will learn:
Lessons learned from GSK’s open source adoption journey,
How collaboration via pharmaverse, PHUSE, and R Consortium accelerates regulatory submissions
How {admiral} package for ADaM datasets was one of the triggers for widespread open source adoption in pharma
Why R is a dominant language in pharma
What are the next milestones to modernize outdated regulatory standards
Where Science Meets Technology by Appsilon is a series of interviews and discussions focused on how technology can accelerate data science processes, particularly within life sciences and biopharmaceutical companies.
Each episode will explore various aspects of innovation and its potential to address challenges where traditional methods may fall short. We will feature internal experts from our delivery teams, along with clients and partners as guest speakers, providing valuable insights into the intersection of science and technology.
The podcast is brought to you by Appsilon.
Appsilon empowers Fortune 500 companies to leverage open-source technology for faster, data-driven decision-making in regulated environments
